Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept in Patients With Exudative Age-related Macular Degeneration

NCT02125864 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02125864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02125864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept in Patients With Exudative Age-related Macular Degeneration
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
November 30, 2014
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration